{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"efpeglenatide","name":"Efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":7,"objects":{"clinicaltrials-gov-nct01093729-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01093729-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct01093729-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01093729-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct01093729-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct01093729-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct01093729-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2014-02-07","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01093729","sourceIds":["ctg-observation-nct01093729-2014-02-07-fe19ee5af625"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01093729 at 2026-11-16T17:34:46.889Z. Its registry update date was 2014-02-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct01093729-2014-02-07-fe19ee5af625"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01093729 at 2026-11-16T17:34:46.889Z. Its registry update date was 2014-02-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct01093729-2014-02-07-fe19ee5af625"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01093729-2014-02-07-fe19ee5af625"]}],"sources":[{"id":"ctg-observation-nct01093729-2014-02-07-fe19ee5af625","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01093729 · retained source version 2014-02-07:fe19ee5af62517592ffc4e10db67e29f5c2ab93c726a6d64bcf346a6963e42ae","url":"https://clinicaltrials.gov/study/NCT01093729"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"37faeaae18e7257cf04706cd93dd3e188108a484dd7aa19ccbd0939c5735c18b","tierARecordSha256":"cd12f6585e7add8f1540dd7352fd06c75b557ed3ffff6d20567e615a61ece545"},"integrity":{"algorithm":"sha256","contentSha256":"73f743ab9e559075e47f8b70b86a113b46cf4918ed20fb2738518cfcd59733f9"}},"clinicaltrials-gov-nct01452451-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01452451-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct01452451-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01452451-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct01452451-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct01452451-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct01452451-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2016-08-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01452451","sourceIds":["ctg-observation-nct01452451-2016-08-09-27d4cd960e9d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct01452451-2016-08-09-27d4cd960e9d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01452451 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct01452451-2016-08-09-27d4cd960e9d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01452451-2016-08-09-27d4cd960e9d"]}],"sources":[{"id":"ctg-observation-nct01452451-2016-08-09-27d4cd960e9d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01452451 · retained source version 2016-08-09:27d4cd960e9d82e0d07dae7ffc3f257965b0be77f1c16664d4d46d897e3329e2","url":"https://clinicaltrials.gov/study/NCT01452451"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c2d59ed30180e1b8e085150a11a59d9131f212d693ae3a68019ad5f1abd84eaf","tierARecordSha256":"bc9cdcf1f36edc90d59b051a6dd4ea3679a1d9efade1a8b3ae718df8c985ce18"},"integrity":{"algorithm":"sha256","contentSha256":"fd70b9c39d72a3d40d4be4e612448092f3049f00377afd24e405c5272bdfefb0"}},"clinicaltrials-gov-nct02075281-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02075281-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct02075281-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02075281-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct02075281-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct02075281-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct02075281-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2016-08-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02075281","sourceIds":["ctg-observation-nct02075281-2016-08-09-2d1d4f05cc5b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02075281 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct02075281-2016-08-09-2d1d4f05cc5b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02075281 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct02075281-2016-08-09-2d1d4f05cc5b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02075281-2016-08-09-2d1d4f05cc5b"]}],"sources":[{"id":"ctg-observation-nct02075281-2016-08-09-2d1d4f05cc5b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02075281 · retained source version 2016-08-09:2d1d4f05cc5b1cbb780abf7442a936265089776d82027d9acc144126a88bfab7","url":"https://clinicaltrials.gov/study/NCT02075281"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"57335bc7e1f0c6ebd6f6fb8243f0a63bc8e89a49b2957534a847781db0185d8b","tierARecordSha256":"866a91042b5b4305ae6e5fd802ad1e6e975d450a87f7e30e4c0d42cfcdd9cb46"},"integrity":{"algorithm":"sha256","contentSha256":"d56813e525b1cb415ee4d49265f8ac0d4e115ab963b02098cdf057739338b862"}},"clinicaltrials-gov-nct02081118-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02081118-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct02081118-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02081118-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct02081118-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct02081118-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct02081118-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2016-08-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02081118","sourceIds":["ctg-observation-nct02081118-2016-08-09-718d57902d27"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02081118 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct02081118-2016-08-09-718d57902d27"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02081118 at 2026-11-16T17:34:46.889Z. Its registry update date was 2016-08-09, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct02081118-2016-08-09-718d57902d27"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02081118-2016-08-09-718d57902d27"]}],"sources":[{"id":"ctg-observation-nct02081118-2016-08-09-718d57902d27","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02081118 · retained source version 2016-08-09:718d57902d27b464b351854d378d9eecaab37d71adf1441c5e897aef79c4a4f1","url":"https://clinicaltrials.gov/study/NCT02081118"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a278903230d076b7ec613bd60e070991fc444b9deebb3b117f06c80fff30b68e","tierARecordSha256":"c196c7571fd70423a4f2f29116f8b4527b2b51eecd773ec0ec5eb0b3ae6b7176"},"integrity":{"algorithm":"sha256","contentSha256":"6dda37ed9a4d5f178790cd759e5fe86f02895d82bb770e926f5f2b0fa80c4ec6"}},"clinicaltrials-gov-nct06174779-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06174779-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct06174779-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06174779-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct06174779-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct06174779-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct06174779-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2026-07-07","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06174779","sourceIds":["ctg-observation-nct06174779-2026-07-07-6ea9ab3dd655"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct06174779-2026-07-07-6ea9ab3dd655"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct06174779-2026-07-07-6ea9ab3dd655"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06174779-2026-07-07-6ea9ab3dd655"]}],"sources":[{"id":"ctg-observation-nct06174779-2026-07-07-6ea9ab3dd655","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06174779 · retained source version 2026-07-07:6ea9ab3dd655c26c28cc00c5bf7a9ea59951786aaeeb15a0e24fd391852d6ed9","url":"https://clinicaltrials.gov/study/NCT06174779"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d7b859b9ab0438ac5161f892d4b5f065251ecce5cf52a74589c8859fdb197a9e","tierARecordSha256":"249290902c6bf48fc089d31806acdceb7c9abbf7474b3fefd8e3734f8a50ce04"},"integrity":{"algorithm":"sha256","contentSha256":"5fd096f3a250a7377d318387058245ba362f24ba506fa7ec99177838042f550c"}},"clinicaltrials-gov-nct07379333-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07379333-efpeglenatide:v1","objectPathId":"clinicaltrials-gov-nct07379333-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07379333-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#clinicaltrials-gov-nct07379333-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#clinicaltrials-gov-nct07379333-efpeglenatide-v1"},"story":{"slug":"clinicaltrials-gov-nct07379333-efpeglenatide","version":1,"domain":"Clinical trials","dateInSource":"2026-05-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07379333","sourceIds":["ctg-observation-nct07379333-2026-05-13-c599578eaa8d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07379333 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-05-13, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct07379333-2026-05-13-c599578eaa8d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07379333 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-05-13, and PeptideScanner's reviewed identity mapping was efpeglenatide.","sourceIds":["ctg-observation-nct07379333-2026-05-13-c599578eaa8d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07379333-2026-05-13-c599578eaa8d"]}],"sources":[{"id":"ctg-observation-nct07379333-2026-05-13-c599578eaa8d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07379333 · retained source version 2026-05-13:c599578eaa8d429e0152e13caf981fed9266ac8441a80524f20f68e1f1aaac63","url":"https://clinicaltrials.gov/study/NCT07379333"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fc4fc90670788c7d591d9dee0534784025eff00b2e5fad64dba66049d1197a9f","tierARecordSha256":"b7050c6e4f9dcca37fde8287b410aae6f566d11a0eff9fed81e199dc486e710c"},"integrity":{"algorithm":"sha256","contentSha256":"a33c7db44b5beed3ca9e783443d9ab7fa17fd1402af099cdfc39252e52766fe2"}},"pubmed-pmid-41403449-efpeglenatide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41403449-efpeglenatide:v1","objectPathId":"pubmed-pmid-41403449-efpeglenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41403449-efpeglenatide/","json":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.json#pubmed-pmid-41403449-efpeglenatide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/efpeglenatide.md#pubmed-pmid-41403449-efpeglenatide-v1"},"story":{"slug":"pubmed-pmid-41403449-efpeglenatide","version":1,"domain":"Literature metadata","dateInSource":"2025-12-19","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["efpeglenatide"],"peptides":[{"slug":"efpeglenatide","url":"https://peptidescanner.com/peptides/efpeglenatide/"}]},"claims":[{"id":"headline","text":"Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes.","sourceIds":["pubmed-observation-pmid-41403449-2025-12-19-c4b41020606e"]},{"id":"summary","text":"PubMed lists PMID 41403449 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2025-12-01 (day precision). PeptideScanner associated the retained record with the identity slug efpeglenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41403449-2025-12-19-c4b41020606e"]},{"id":"paragraph-1","text":"PubMed lists PMID 41403449 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2025-12-01 (day precision). PeptideScanner associated the retained record with the identity slug efpeglenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41403449-2025-12-19-c4b41020606e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41403449-2025-12-19-c4b41020606e"]}],"sources":[{"id":"pubmed-observation-pmid-41403449-2025-12-19-c4b41020606e","name":"PubMed","sourceClass":"A","title":"Population pharmacokinetics of efpeglenatide in individuals with obesity and with type 2 diabetes. · retained source version 1:2025-12-19:current:c4b41020606edfcd3c037cca0eb5c15476eb550109c5e1bd09d0e47050381652","url":"https://pubmed.ncbi.nlm.nih.gov/41403449/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a18d6ae8e2327225cb20e472b6a057bcc262a13d29473fc359376f01cf59d8e4","tierARecordSha256":"5bc3fbe4526038b8124209f40776281f70701ad61ca719500690d90b13124c6d"},"integrity":{"algorithm":"sha256","contentSha256":"4b32c5a177d4feeeba643ed9a4e94edc5ba904c86d141fe718689630dd8919e0"}}}}
